Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > SEMATECH Names Daniel Armbrust as President and CEO

Abstract:
SEMATECH, the global consortium of semiconductor manufacturers, today announced that it has named Daniel Armbrust to serve as its President and Chief Executive Officer. Armbrust will succeed Michael R. Polcari, who has been appointed SEMATECH's Chairman of the Board.

SEMATECH Names Daniel Armbrust as President and CEO

Austin, TX and Albany, NY | Posted on November 16th, 2009

Armbrust, 47, most recently served as Vice President of 300mm Semiconductor Operation, where he was responsible for the operation of IBM's 300mm fab in East Fishkill, New York, which develops leading edge technologies with IBM's alliance partners and manufactures products for IBM and OEM customers. Previously Armbrust held a variety of positions at IBM related to process development, manufacturing, and client engagement.

Michael Polcari, SEMATECH's newly appointed Chairman of the Board, said that the SEMATECH board selected Armbrust to lead the consortium based on his track record of leadership and execution in developing leading edge technologies, directing fab operations, and managing complex alliances.

"Our search for a new leader for SEMATECH was focused and thorough," said Polcari. "Dan came to our attention because of his proven ability to lead top performing teams, his strong credentials in both R&D and manufacturing, and his experience in driving strategic alliances. Dan has the right blend of talents for the job, and we are delighted to welcome him to SEMATECH."

Armbrust said, "SEMATECH is one of the world's leading consortia, with a proud history, outstanding talent and significant technical innovations in many of its programs. SEMATECH has played a pivotal role in our industry, and it's a great honor to join its leadership team and have the opportunity to build on its success."

Armbrust will assume his new duties immediately, replacing Michael R. Polcari, who has been SEMATECH's President and CEO since February 2003. Polcari succeeds OB Bilous as Chairman of SEMATECH's Board of Directors.

Daniel Armbrust biography

Daniel Armbrust was named President and Chief Executive Officer of SEMATECH on November 12, 2009. The appointment is effective immediately.

Armbrust previously spent 25 years at IBM Corporation, culminating in his tenure as Vice President of 300mm Semiconductor Operations for the company's Systems Technology Group. His leadership was marked by successful efforts to improve operating efficiency, lead executive collaborations within the industry, and build strong technical teams.

Prior to his role as Vice President, Armbrust served as Director of 300mm Engineering and Strategic Client Executive for IBM's Systems and Technology Group. He began his career at IBM in 1983 and progressed through a variety of assignments in process development, manufacturing and client engagement.

Armbrust earned a bachelor's degree in ceramic science and engineering from Pennsylvania State University as well as a master of science degree in manufacturing systems engineering from Rensselaer Polytechnic Institute.

####

About SEMATECH
For over 20 years, SEMATECH® has set global direction, enabled flexible collaboration, and bridged strategic R&D to manufacturing.

Today, we continue accelerating the next technology revolution with our nanoelectronics and emerging technology partners.

For more information, please click here

Contacts:
Erica McGill
SEMATECH
Media Relations
257 Fuller Road
Suite 2200
Albany, NY | 12203
o: 518-649-1041
m: 518-487-8256

Copyright © SEMATECH

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Appointments/Promotions/New hires/Resignations/Deaths

Jim Barnhart Joins Nanometrics as Senior Vice President of Operations March 15th, 2018

Jonathan Chou to Join Nanometrics as Chief Financial Officer February 26th, 2018

Ocean Optics Grows Sales Organization with Executive Appointments: Henry Langston promoted, Christine Stannard joins spectral sensing product developer December 23rd, 2017

Emmanuel Sabonnadiere is Leti’s New CEO November 28th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project